Antabuse, a drug commonly prescribed to treat alcohol use disorder, may help to restore eyesight in people with genetic retinitis pigmentosa and other disorders associated with retinal degeneration.
Study reveals C3, which can cause damage in some eye diseases, may help to slow the progression of retinitis pigmentosa.
Gene therapy that targets retinal ganglion cells with light-sensitive cone opsins helps restore vision in mice. Researchers report a potential human treatment could be available within three years.
Researchers use gene editing to reverse cell degeneration and restore vision in mouse models of retinitis pigmentosa.
A new study uses retinal prosthetics to assess the brain's ability to process visual information years after blindness occurs.
Surgeons have successfully performed the world's first operation inside the eye using a robot.
A team of researchers used CRISPR, a new gene editing technology, to repair a genetic mutation responsible for retinitis pigmentosa.
Retinal implants may improve image sharpness for those who have lost their vision due to retinitis pigmentosa, a new study reports.
A British woman is able to read the time clearly for the first time in years after receiving a new bionic eye implant.
Researchers have developed a new type of nanowire material that may improve both retinal and brain implants.
Researchers report they have been successful in restoring vision to mice with retinitis pigmentosa.
Researchers use simulations to mimic what vision could be like after a patient undergoes one of two different vision restoring therapies.
